Skip to main content
. 2024 Feb 29;13(5):e031305. doi: 10.1161/JAHA.123.031305

Figure 3. New‐onset RHF at 3 months post LVAD implantation: kidney function trajectories (and 95% CIs) before and after RHF ascertainment at 3‐month follow‐up visit.

Figure 3

A, Predicted eGFR trajectories from the time of implantation to 3 months following implantation, by RHF status at 3 months. B, Predicted eGFR trajectories from 3 months to 12 months following LVAD implantation, by RHF status at 3 months. Predictions are estimated marginal means of eGFR. These predictions are based on the means of continuous variables and averaging over predictions using all values of categorical variables. Covariates were age, sex, INTERMACS profile, diabetes, use of IV inotropes at implantation, LVEF<20% at implantation, severe RV dysfunction at implantation, previous tricuspid valve repair or replacement, mechanical ventilation at baseline, blood urea nitrogen to creatinine ratio at baseline, device type (centrifugal or axial flow), and primary cardiac disease. eGFR indicates estimated glomerular filtration rate; INTERMACS, Interagency Registry for Mechanically Assisted Circulatory Support; LVAD, left ventricular assist device; LVEF, left ventricular ejection fraction; RHF, right heart failure; and RV, right ventricle.